Sagaliam Acquisition Corp. announced that it has amended the executed non-binding term sheet for the purchase of Biogenysis Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. amending the combined purchase price to $450,000,000. Additionally, the company announce that Ronnie Richardson, Krystine Miller, and Travis Richardson are joining Board of Directors.
Sagaliam Acquisition Corp.
Equities
SAGA
US78661R1068
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+160.11% | 8.04B | |
+2.33% | 984M | |
+41.91% | 883M | |
+20.44% | 788M | |
+2.11% | 666M | |
+5.03% | 621M | |
-.--% | 600M | |
+7.78% | 524M | |
-.--% | 500M |